Provided by Tiger Fintech (Singapore) Pte. Ltd.

Solid Biosciences

4.72
-0.0900-1.87%
Post-market: 4.820.1038+2.20%19:32 EDT
Volume:7.02M
Turnover:33.16M
Market Cap:365.87M
PE:-1.62
High:4.85
Open:4.77
Low:4.64
Close:4.81
Loading ...

Solid Biosciences Initiated at Buy by Citigroup

Dow Jones
·
26 Jun

Solid Biosciences (SLDB) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
17 Jun

Solid Biosciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Jun

Solid Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
14 Jun

Solid Biosciences Price Target Maintained With a $15.00/Share by JMP Securities

Dow Jones
·
06 Jun

Solid Biosciences reports inducement grants under Nasdaq listing rule

TIPRANKS
·
03 Jun

Solid Biosciences Reports Increased Loss Amid R&D Expansion

TIPRANKS
·
31 May

Solid Biosciences Coverage Assumed by Cantor Fitzgerald at Overweight

Dow Jones
·
22 May

Solid Biosciences: Undervalued Gem with Promising Gene Therapy Pipeline and Upcoming Catalysts

TIPRANKS
·
22 May

Solid Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
19 May

Chardan Adjusts Price Target on Solid Biosciences to $15 From $16, Maintains Buy Rating

MT Newswires Live
·
19 May

Solid Biosciences’ SGT-003 Therapy Shows Promise in DMD Treatment, Earning Buy Rating from Analyst

TIPRANKS
·
19 May

Wedbush Sticks to Its Buy Rating for Solid Biosciences (SLDB)

TIPRANKS
·
18 May

Solid Biosciences Is Maintained at Overweight by Barclays

Dow Jones
·
16 May

Solid Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May

Wedbush Cuts Price Target on Solid Biosciences to $17 From $18, Keeps Outperform Rating

MT Newswires Live
·
16 May

Solid Biosciences: Promising Gene Therapy Advancements and Strategic Initiatives Drive Buy Rating

TIPRANKS
·
16 May

Solid Biosciences : Barclays Cuts Target Price to $10 From $15

THOMSON REUTERS
·
16 May

Solid Biosciences price target lowered to $10 from $15 at Barclays

TIPRANKS
·
16 May

Solid Biosciences: Promising Developments and Potential Growth in Duchenne Muscular Dystrophy Treatment

TIPRANKS
·
16 May